Skye Bioscience Inc. Insider Trading
SKYE
Insiders sold 445K and bought nothing on the open market.
None of the selling was scheduled in advance under a 10b5-1 plan. Director Andrew J. Schwab sold 240K on Sep 23, 13% of their stake, outside a plan. The last open-market buy by an executive or director was in Aug 2023.
Get an email when SKYE's executives or directors buy, or make a large sale outside a plan.
Trades · last 2 years
| Date | Insider | Trade | Shares | Price | Value | Of their stake | Filing |
|---|---|---|---|---|---|---|---|
| Sep 22 – 23 | Andrew J. Schwab Director | SoldNo plan 4 parts | 148,079 | $1.62 average | 240K | 13% | Form 4 |
| Sep 22 – 23 | 5AM Ventures II LP Large holder | SoldNo plan 4 parts | 148,079 | $1.62 average | 240K | 13% | Form 4 |
| Sep 16 | Andrew J. Schwab Director | SoldNo plan 2 parts | 33,892 | $1.91 average | 65K | 2.9% | Form 4 |
| Sep 16 | Kush Parmar Large holder | SoldNo plan 2 parts | 33,892 | $1.91 average | 65K | 2.9% | Form 4 |
| Aug 18 – 20 | Andrew J. Schwab Director | SoldNo plan 9 parts | 375,840 | $0.37 average | 140K | 3.9% | Form 4 |
| Aug 18 – 20 | 5AM Partners II, LLC Large holder | SoldNo plan 9 parts | 375,840 | $0.37 average | 140K | 3.9% | Form 4 |
| Aug 21, 2025 – Aug 22, 2025 | Andrew J. Schwab Director | SoldNo plan 4 parts | 231,405 | $3.46 average | 801K | 2.3% | Form 4 |
| Aug 21, 2025 – Aug 22, 2025 | Scott M Rocklage Large holder | SoldNo plan 4 parts | 231,405 | $3.46 average | 801K | 2.3% | Form 4 |
- Sep 22 – 23No planAndrew J. SchwabDirector · sold 148,079 at avg $1.62240K13% of stake
- Sep 22 – 23No plan5AM Ventures II LPLarge holder · sold 148,079 at avg $1.62240K13% of stake
- Sep 16No planAndrew J. SchwabDirector · sold 33,892 at avg $1.9165K2.9% of stake
- Sep 16No planKush ParmarLarge holder · sold 33,892 at avg $1.9165K2.9% of stake
- Aug 18 – 20No planAndrew J. SchwabDirector · sold 375,840 at avg $0.37140K3.9% of stake
- Aug 18 – 20No plan5AM Partners II, LLCLarge holder · sold 375,840 at avg $0.37140K3.9% of stake
- Aug 21, 2025 – Aug 22, 2025No planAndrew J. SchwabDirector · sold 231,405 at avg $3.46801K2.3% of stake
- Aug 21, 2025 – Aug 22, 2025No planScott M RocklageLarge holder · sold 231,405 at avg $3.46801K2.3% of stake
Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.
Peers
Pharmaceutical Preparations · Pick stocks to compare with SKYE
Spot a number that looks wrong? Check it in SKYE's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing SKYE
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.